U.S. maker of experimental Ebola drug ZMapp seeks to boost output
October 10, 2014 at 14:16 PM EDT
Oct 10 (Reuters) - California-based Mapp Biopharmaceutical Inc is making progress in efforts to boost production of the experimental Ebola treatment ZMapp, as the deadly virus continues to spread through West Africa and beyond, the company said Friday.